Norway vs Peru: Proportion of isolates with decreased susceptibility or resistance
Norway
0
in 2018
Peru
0
in 2018
Norway rank
25th
Peru rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- Norway
- Peru
How they compare
Norway currently reports 0 against 0 in Peru, a difference of 0.
The two have swapped places 3 times across 6 shared years of data; in 2009 it was Norway ahead.
Norway ranks 25th and Peru ranks 25th of 51 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.9091 | 0 | 0.9091 | Norway |
| 2010s | 1.81 | 0.4762 | 1.34 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Norway or Peru?
- Norway, at 0 against 0 in Peru as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Norway and Peru?
- 0, with Norway ahead.
- How many years of comparable data are there for Norway and Peru?
- 6 years are reported by both, from 2009 to 2018.
- How do Norway and Peru rank globally for proportion of isolates with decreased susceptibility or resistance?
- Norway ranks 25th and Peru ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.